Compare DOMH & OFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | DOMH | OFS |
|---|---|---|
| Founded | 1967 | 2001 |
| Country | United States | United States |
| Employees | N/A | 53 |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 55.0M | 57.2M |
| IPO Year | 2010 | N/A |
| Metric | DOMH | OFS |
|---|---|---|
| Price | $2.93 | $2.84 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 65.7K | ★ 113.0K |
| Earning Date | 04-14-2026 | 03-02-2026 |
| Dividend Yield | ★ 22.18% | 21.73% |
| EPS Growth | ★ 39.75 | N/A |
| EPS | ★ 7.86 | N/A |
| Revenue | ★ $18,146,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $0.37 | $17.44 |
| Revenue Growth | ★ 789.95 | N/A |
| 52 Week Low | $2.82 | $3.06 |
| 52 Week High | $8.40 | $9.52 |
| Indicator | DOMH | OFS |
|---|---|---|
| Relative Strength Index (RSI) | 35.94 | 19.33 |
| Support Level | $2.85 | N/A |
| Resistance Level | $3.56 | $5.33 |
| Average True Range (ATR) | 0.21 | 0.17 |
| MACD | 0.01 | -0.07 |
| Stochastic Oscillator | 10.14 | 4.65 |
Dominari Holdings Inc through its various subsidiaries, is currently engaged in wealth management, investment banking, securities sales and trading and asset management. The company operates in two reportable business segments: Dominari Financial and Legacy AIkido. The Dominari Financial reportable business segment represents the Company's broker-dealer business, which is composed of mostly underwriting and transactional service activities. The Legacy AIkido reportable business segment includes Aikido Labs, which manages the investments holdings of the legacy entity. It generates the majority of its revenue from the Dominari Financial segment.
OFS Capital Corp is an externally managed, closed-end, non-diversified management investment company. Its business objective is to generate current income and capital appreciation by investing in middle-market companies in the United States. The company focuses on investments in senior secured loans, including first lien, second lien, and unitranche loans, as well as subordinated loans and, to a lesser extent, warrants, and other equity securities.